Congenital Hyperinsulinism: Report of a New Mutation

Journal Title: Open Access Journal of Endocrinology - Year 2018, Vol 2, Issue 1

Abstract

Congenital hyperinsulinism is a rare condition characterized by inappropriate secretion of insulin leading to recurrent and persistent hypoglycaemia, which may subsequently lead to permanent brain damage. Genetic mutations have been identified in approximately 50% of cases attributable to defects in at least 11 genes. The clinical presentation is nonspecific. Seizures during infancy or pallor, diaphoresis and tachycardia, in childhood, can be the first presentation. Medical treatment includes diazoxide, chlorthiazide, nifedipine and octreotide. In diazoxide unresponsive patients, further investigations including genetic studies and 18F-DOP PET scan may be warranted to identify the two distinct types of congenital hyperinsulinism described in the literature: focal and diffuse forms. Focal hyperinsulinism may be cured by excision of the focal lesion; whereas, diffuse hyperinsulinism may require near-total pancreatectomy. We report a female newborn with focal hyperinsulinism but with multifocal lesions. This is rarely described in the current literature. The genetic mutation identified in our case was ABCC8c.1792C>Tp.Arg598* of paternal origin, a new mutation, not previously described in the literature. Due to the multifocal nature of this form of hyperinsulinism, the patient developed recurrent episodes of hypoglycaemia despite excision of the focal lesion. Further genetic studies may be necessary in the identification of possible genetic mutations associated with multifocal hyperinsulinism, which may aid the management and predict the prognosis.

Authors and Affiliations

Jorge Sales Marques

Keywords

Related Articles

Aetiology, Clinical Profile and Management Dilemmas in Transgender Children with Y Containing Chromosomes: The Tip of an Iceberg

Background: Difficulty in reaching an aetiological diagnosis and management issues are more in XY Disorders of Sex Development (DSD) than XX DSD. Clinical features are also similar between various aetiological types. Ob...

Sunitinib Induced Hypocalcemia and its Potential Role in the Treatment of Refractory Hypercalcemia

Background: Sunitinib, an oral multi-targeted tyrosine kinase inhibitor has been approved for the treatment of advanced pancreatic neuroendocrine neoplasms (pNENs). Aim: To describe a series of 12 patients with pNENs on...

Spectrum of Diabetic Kidney Disease in India - A Tertiary Care Centre Experience

Objectives / Aim of study: To assess the magnitude, clinico-social risk factors and associations of diabetic kidney disease in type 2 diabetes subjects attending a tertiary care centre in Eastern India. Materials and Me...

Lymphadenopathy in Autoimmune Thyroiditis: Paratracheal Lymph Nodes are Indeed Crucial

Cervical lymphadenopathy is common in patients with autoimmune thyroiditis and supposed to be pathognomic for the disease if found in the paratracheal compartment (Robbins level VI). The aim of this prospective study is...

Papillary Carcinoma in Thyroglossal Duct Cyst

Objective: To report four cases of Papillary carcinoma on a Thyroglossal Duct Cyst and discuss their diagnosis and management. Method : Retrospective analysis of medical records from patients diagnosed and treated with...

Download PDF file
  • EP ID EP448832
  • DOI 10.23880/oaje-16000118
  • Views 55
  • Downloads 0

How To Cite

Jorge Sales Marques (2018). Congenital Hyperinsulinism: Report of a New Mutation. Open Access Journal of Endocrinology, 2(1), 1-6. https://europub.co.uk/articles/-A-448832